105.50
0.00
(0.00%)
At close: January 17 at 2:40:22 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 10 | 10 |
| Avg. Estimate | 79.5M | 88.19M | 375.33M | 500.51M |
| Low Estimate | 71.6M | 79M | 349.1M | 392.02M |
| High Estimate | 86.68M | 94.99M | 411.51M | 572M |
| Year Ago Sales | 46.02M | 73.22M | 333.62M | 375.33M |
| Sales Growth (year/est) | 72.74% | 20.44% | 12.50% | 33.35% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ARDX.MX | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Initiated | Scotiabank: Sector Outperform | 3/7/2025 |
| Reiterates | Raymond James: Strong Buy to Strong Buy | 2/21/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 2/21/2025 |
| Maintains | Piper Sandler: Neutral to Neutral | 1/27/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 1/16/2025 |
| Maintains | Jefferies: Buy to Buy | 1/2/2025 |
Related Tickers
B9A.F BioArctic AB (publ)
16.79
+12.46%
RPD.MU Royalty Pharma plc
28.20
0.00%
HQ1.MU Oruka Therapeutics Inc. R
7.05
+6.02%
7PO.F Poxel S.A.
0.4510
-11.39%
2HA.F Spero Therapeutics, Inc.
0.6170
+16.64%
05Y.MU Vivoryon Therapeutics NV
1.7440
-4.49%
BT3.BE Lineage Cell Therapeutics Inc
0.3800
-5.47%
PROT Proteonomix, Inc.
0.0000
0.00%
P0F.F Egetis Therapeutics AB (publ)
0.2955
-4.68%
ICY.HA Incyte Corp
52.14
+1.76%